CClinicalTrials.gg
Status unknownNCT05767957Updated Mar 14, 2023

Contribution Of Cognitivo-Behavorial Therapy In Shoulder Apprehension

An interventional study of Rehabilitation physiotherapy and Cognitive-behavioral therapies in addition to rehabilitation physiotherapy in Shoulder Dislocation and Shoulder Instability, sponsored by Centre Epaule Coude CEPCO. Status unknown at 2 sites in Switzerland. Open to participants aged 15 Years to 45 Years. Per ClinicalTrials.gov, last updated 2023-03-14.

Sponsored by Centre Epaule Coude CEPCO · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Jan 2022, registered Jul 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Ages
15 Years to 45 Years
Sex
All
01

Study summary

Randomized controlled double-blind study aimed at studying the contribution of cognitive-behavioral therapy in the treatment of shoulder apprehension. Comparison of 2 physiotherapy techniques in the context of shoulder instability.

Control group: rehabilitation physiotherapy by physiotherapist using conventional technique alone.

Intervention group: rehabilitation physiotherapy by physiotherapist according to conventional technique, with the addition of techniques from cognitive-behavioral therapies.

Read the detailed description

Traumatic anterior instability of the shoulder is one of the most frequent lesions of the shoulder, the majority of cases of which occur in adolescents, with a risk of recurrence close to 90% if it occurs before the age of 20 years. It can be treated conservatively or surgically. Stabilizing surgery of the glenohumeral joint offers satisfactory results for people suffering from shoulder instability. Like subjects treated conservatively, patients undergoing stabilizing surgery remain apprehensive after the operation in 2 to 51% of cases. Currently, no rehabilitation program has demonstrated superior effectiveness, during instability treated conservatively or during postoperative rehabilitation. Recent studies have shown that cortical reorganization takes place, especially in areas of fear and anxiety. Faced with the need to develop physiotherapeutic management in post-traumatic unstable shoulder, this study aims to evaluate the contribution of cognitive-behavioral therapy, by including a neuropsychological axis in the rehabilitation of patients.

This study is randomized and controlled, multicenter, including 144 patients suffering from apprehension of the shoulder, divided into two treatment groups. Both groups will receive a conventional physiotherapy protocol including individual sessions and home exercises. The physiotherapists in the intervention group will also have received training in the use of techniques from Cognitive-Behavioral Therapies. Data will be collected before the introduction of physiotherapy, after 6, 12, 24 and 52 weeks of treatment. In the event of surgery, the data will also be collected preoperatively. The primary outcome is apprehension measured by the Rowe score. The secondary outcomes are apprehension measured by the apprehension and relocation tests, and the Tampa Scale for Kinesiophobia, as well as shoulder function, measured by the Simple Shoulder Test and the Subjective Shoulder Value.

02

Conditions studied

  • Shoulder Dislocation
  • Shoulder Instability

Browse trials for

03

In context

Shoulder Dislocation

103 studies on the registry are indexed under Shoulder Dislocation; 23 are open to participants now.

This study's planned enrollment of 144 is above the median of 60 across 70 interventional studies indexed under Shoulder Dislocation.

Browse Shoulder Dislocation studies →

Lead sponsor

This is the only study on the registry with Centre Epaule Coude CEPCO as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • positive apprehension test;
  • traumatic anterior dislocation of the glenohumeral joint requiring or not surgical stabilization according to Bankart or Latarjet;
  • good oral and written comprehension of French;
  • age between 15 and 45 years old.

Exclusion criteria

Exclusion Criteria:

  • associated tendon injury requiring surgical treatment;
  • fracture other than Bankart fracture;
  • multidirectional instability (MDI);
  • peripheral neurological lesion in the upper limb;
  • central neurological lesion;
  • diagnosed psychosis, depression or epilepsy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
144 participants (estimated)

Study arms

  • Active comparator
    Control group

    Other: Rehabilitation physiotherapy

  • Experimental
    Intervention group

    Other: Cognitive-behavioral therapies in addition to rehabilitation physiotherapy

Interventions

  • OtherRehabilitation physiotherapy

    Rehabilitation physiotherapy by physiotherapist using conventional technique alone.

  • OtherCognitive-behavioral therapies in addition to rehabilitation physiotherapy

    Rehabilitation physiotherapy by physiotherapist according to conventional technique, with the addition of techniques from cognitive-behavioral therapies.

06

What researchers measure

Primary outcomes

  1. Rowe score

    Score for Shoulder Stability; 0-100 points (excellent: 90-100 pts; good: 75-89 pts; average: 51-74 pts; bad: \<50 pts)

    Time frame: enrolment

  2. Rowe score

    Score for Shoulder Stability; 0-100 points (excellent: 90-100 pts; good: 75-89 pts; average: 51-74 pts; bad: \<50 pts)

    Time frame: 6 weeks

  3. Rowe score

    Score for Shoulder Stability; 0-100 points (excellent: 90-100 pts; good: 75-89 pts; average: 51-74 pts; bad: \<50 pts)

    Time frame: 3 months

  4. Rowe score

    Score for Shoulder Stability; 0-100 points (excellent: 90-100 pts; good: 75-89 pts; average: 51-74 pts; bad: \<50 pts)

    Time frame: 6 months

  5. Rowe score

    Score for Shoulder Stability; 0-100 points (excellent: 90-100 pts; good: 75-89 pts; average: 51-74 pts; bad: \<50 pts)

    Time frame: 12 months

Secondary outcomes

  1. Shoulder Range Of Motion: flexion

    unit of measure: angle 0-180° degrees (worst: 0°; best: 180°); measurement tool: goniometer

    Time frame: enrolment

  2. Shoulder Range Of Motion: flexion

    unit of measure: angle 0-180° degrees (worst: 0°; best: 180°); measurement tool: goniometer

    Time frame: 3 months

  3. Shoulder Range Of Motion: flexion

    unit of measure: angle 0-180° degrees (worst: 0°; best: 180°); measurement tool: goniometer

    Time frame: 6 months

  4. Shoulder Range Of Motion: flexion

    unit of measure: angle 0-180° degrees (worst: 0°; best: 180°); measurement tool: goniometer

    Time frame: 12 months

  5. Shoulder Range Of Motion: abduction

    unit of measure: angle 0-180° degrees (worst: 0°; best: 180°); measurement tool: goniometer

    Time frame: enrolment

  6. Shoulder Range Of Motion: abduction

    unit of measure: angle 0-180° degrees (worst: 0°; best: 180°); measurement tool: goniometer

    Time frame: 3 months

  7. Shoulder Range Of Motion: abduction

    unit of measure: angle 0-180° degrees (worst: 0°; best: 180°); measurement tool: goniometer

    Time frame: 6 months

  8. Shoulder Range Of Motion: abduction

    unit of measure: angle 0-180° degrees (worst: 0°; best: 180°); measurement tool: goniometer

    Time frame: 12 months

  9. Shoulder Range Of Motion: external rotation

    unit of measure: angle 0-90° degrees (worst: 0°; best: 90°); measurement tool: goniometer

    Time frame: enrolment

  10. Shoulder Range Of Motion: external rotation

    unit of measure: angle 0-90° degrees (worst: 0°; best: 90°); measurement tool: goniometer

    Time frame: 3 months

  11. Shoulder Range Of Motion: external rotation

    unit of measure: angle 0-90° degrees (worst: 0°; best: 90°); measurement tool: goniometer

    Time frame: 6 months

  12. Shoulder Range Of Motion: external rotation

    unit of measure: angle 0-90° degrees (worst: 0°; best: 90°); measurement tool: goniometer

    Time frame: 12 months

  13. Shoulder Range Of Motion: internal rotation

    unit of measure: height of the position of the hand in the back according to anatomical landmarks; 1- lateral thigh, 2- buttock, 3- lumbosacral junction, 4- waist (L3 vertebra), 5- T12 vertebra, 6- interscapular (T7 vertebra) (worst: 1; best: 6)

    Time frame: enrolment

  14. Shoulder Range Of Motion: internal rotation

    unit of measure: height of the position of the hand in the back according to anatomical landmarks; 1- lateral thigh, 2- buttock, 3- lumbosacral junction, 4- waist (L3 vertebra), 5- T12 vertebra, 6- interscapular (T7 vertebra) (worst: 1; best: 6)

    Time frame: 3 months

  15. Shoulder Range Of Motion: internal rotation

    unit of measure: height of the position of the hand in the back according to anatomical landmarks; 1- lateral thigh, 2- buttock, 3- lumbosacral junction, 4- waist (L3 vertebra), 5- T12 vertebra, 6- interscapular (T7 vertebra) (worst: 1; best: 6)

    Time frame: 6 months

  16. Shoulder Range Of Motion: internal rotation

    unit of measure: height of the position of the hand in the back according to anatomical landmarks; 1- lateral thigh, 2- buttock, 3- lumbosacral junction, 4- waist (L3 vertebra), 5- T12 vertebra, 6- interscapular (T7 vertebra) (worst: 1; best: 6)

    Time frame: 12 months

  17. Rotator cuff strength: anterior cuff

    scale 0-5 (0/5: no contraction ; 1/5: muscle contraction visible, no motion; 2/5: motion with gravity eliminated; 3/5: motion against gravity; 4/5: motion against moderate resistance; 5/5: normal muscle strength)

    Time frame: enrolment

  18. Rotator cuff strength: anterior cuff

    scale 0-5 (0/5: no contraction ; 1/5: muscle contraction visible, no motion; 2/5: motion with gravity eliminated; 3/5: motion against gravity; 4/5: motion against moderate resistance; 5/5: normal muscle strength)

    Time frame: 3 months

  19. Rotator cuff strength: anterior cuff

    scale 0-5 (0/5: no contraction ; 1/5: muscle contraction visible, no motion; 2/5: motion with gravity eliminated; 3/5: motion against gravity; 4/5: motion against moderate resistance; 5/5: normal muscle strength)

    Time frame: 6 months

  20. Rotator cuff strength: anterior cuff

    scale 0-5 (0/5: no contraction ; 1/5: muscle contraction visible, no motion; 2/5: motion with gravity eliminated; 3/5: motion against gravity; 4/5: motion against moderate resistance; 5/5: normal muscle strength)

    Time frame: 12 months

  21. Rotator cuff strength: superior cuff

    scale 0-5 (0/5: no contraction ; 1/5: muscle contraction visible, no motion; 2/5: motion with gravity eliminated; 3/5: motion against gravity; 4/5: motion against moderate resistance; 5/5: normal muscle strength)

    Time frame: enrolment

  22. Rotator cuff strength: superior cuff

    scale 0-5 (0/5: no contraction ; 1/5: muscle contraction visible, no motion; 2/5: motion with gravity eliminated; 3/5: motion against gravity; 4/5: motion against moderate resistance; 5/5: normal muscle strength)

    Time frame: 3 months

  23. Rotator cuff strength: superior cuff

    scale 0-5 (0/5: no contraction ; 1/5: muscle contraction visible, no motion; 2/5: motion with gravity eliminated; 3/5: motion against gravity; 4/5: motion against moderate resistance; 5/5: normal muscle strength)

    Time frame: 6 months

  24. Rotator cuff strength: superior cuff

    scale 0-5 (0/5: no contraction ; 1/5: muscle contraction visible, no motion; 2/5: motion with gravity eliminated; 3/5: motion against gravity; 4/5: motion against moderate resistance; 5/5: normal muscle strength)

    Time frame: 12 months

  25. Rotator cuff strength: posterior cuff

    scale 0-5 (0/5: no contraction ; 1/5: muscle contraction visible, no motion; 2/5: motion with gravity eliminated; 3/5: motion against gravity; 4/5: motion against moderate resistance; 5/5: normal muscle strength)

    Time frame: enrolment

  26. Rotator cuff strength: posterior cuff

    scale 0-5 (0/5: no contraction ; 1/5: muscle contraction visible, no motion; 2/5: motion with gravity eliminated; 3/5: motion against gravity; 4/5: motion against moderate resistance; 5/5: normal muscle strength)

    Time frame: 3 months

  27. Rotator cuff strength: posterior cuff

    scale 0-5 (0/5: no contraction ; 1/5: muscle contraction visible, no motion; 2/5: motion with gravity eliminated; 3/5: motion against gravity; 4/5: motion against moderate resistance; 5/5: normal muscle strength)

    Time frame: 6 months

  28. Rotator cuff strength: posterior cuff

    scale 0-5 (0/5: no contraction ; 1/5: muscle contraction visible, no motion; 2/5: motion with gravity eliminated; 3/5: motion against gravity; 4/5: motion against moderate resistance; 5/5: normal muscle strength)

    Time frame: 12 months

  29. Apprehension test

    examiner flexes the patient's elbow to 90° and abducts shoulder to 90°, then slowly externally rotates the patient's shoulder; the patient demonstrates apprehension during shoulder external rotation at different positions as follow: 1- early, 2- cocked position, 3- forced external rotation, 4- forced external rotation with posterior-anterior pressure (worst: 1; best: 4)

    Time frame: enrolment

  30. Apprehension test

    examiner flexes the patient's elbow to 90° and abducts shoulder to 90°, then slowly externally rotates the patient's shoulder; the patient demonstrates apprehension during shoulder external rotation at different positions as follow: 1- early, 2- cocked position, 3- forced external rotation, 4- forced external rotation with posterior-anterior pressure (worst: 1; best: 4)

    Time frame: 3 months

  31. Apprehension test

    examiner flexes the patient's elbow to 90° and abducts shoulder to 90°, then slowly externally rotates the patient's shoulder; the patient demonstrates apprehension during shoulder external rotation at different positions as follow: 1- early, 2- cocked position, 3- forced external rotation, 4- forced external rotation with posterior-anterior pressure (worst: 1; best: 4)

    Time frame: 6 months

  32. Apprehension test

    examiner flexes the patient's elbow to 90° and abducts shoulder to 90°, then slowly externally rotates the patient's shoulder; the patient demonstrates apprehension during shoulder external rotation at different positions as follow: 1- early, 2- cocked position, 3- forced external rotation, 4- forced external rotation with posterior-anterior pressure (worst: 1; best: 4)

    Time frame: 12 months

  33. Subjective apprehension

    scale 0-10 (0: no apprehension at all (= best outcome); 10: maximal apprehension (= worst outcome))

    Time frame: enrolment

  34. Subjective apprehension

    scale 0-10 (0: no apprehension at all (= best outcome); 10: maximal apprehension (= worst outcome))

    Time frame: 3 months

  35. Subjective apprehension

    scale 0-10 (0: no apprehension at all (= best outcome); 10: maximal apprehension (= worst outcome))

    Time frame: 6 months

  36. Subjective apprehension

    scale 0-10 (0: no apprehension at all (= best outcome); 10: maximal apprehension (= worst outcome))

    Time frame: 12 months

  37. Relocation test

    positive/negative; patient's shoulder is brought into 90° of abduction and maximal external rotation until the patient feels apprehension; examiner gives an antero-posterior (AP) directed pressure at the humeral head; test positive if fear of luxation is reduced after the AP pressure is applied

    Time frame: enrolment

  38. Relocation test

    positive/negative; patient's shoulder is brought into 90° of abduction and maximal external rotation until the patient feels apprehension; examiner gives an antero-posterior (AP) directed pressure at the humeral head; test positive if fear of luxation is reduced after the AP pressure is applied

    Time frame: 3 months

  39. Relocation test

    positive/negative; patient's shoulder is brought into 90° of abduction and maximal external rotation until the patient feels apprehension; examiner gives an antero-posterior (AP) directed pressure at the humeral head; test positive if fear of luxation is reduced after the AP pressure is applied

    Time frame: 6 months

  40. Relocation test

    positive/negative; patient's shoulder is brought into 90° of abduction and maximal external rotation until the patient feels apprehension; examiner gives an antero-posterior (AP) directed pressure at the humeral head; test positive if fear of luxation is reduced after the AP pressure is applied

    Time frame: 12 months

07

Study locations

2 of 2 sites recruiting
  • Centre Epaule Coude CEPCO
    Geneva, 1206, Switzerland
    • Benoît Borner · Contact · benoit.borner@bluewin.ch · +41 79 430 17 26
    • Benoît Borner · Sub investigator
    • Gregory Cunningham · Principal investigator
    Recruiting
  • Hôpital La Tour
    Meyrin, 1217, Switzerland
    • Benoît Borner · Contact · benoit.borner@bluewin.ch · +41 79 430 17 26
    • Alexandre Laedermann · Principal investigator
    • Yannick Thilby · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05767957
Lead sponsor
Centre Epaule Coude CEPCO
Collaborators
Gregory Cunningham, Alexandre Laedermann, Benoît Borner, Yannick Thilby, Suzanne Gard
Responsible party
Sponsor
First posted
Mar 14, 2023
Start date
Jan 1, 2022
Primary completion
Jan 31, 2022
Completion
Dec 31, 2024 (estimated)
Last update
Mar 14, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion